Philips Announces its Global Partnership with the Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) announced its partnership with the Global Initiative for Chronic Obstructive Lung Disease (GOLD), on the occasion of World Chronic Obstructive Pulmonary Disease (COPD) Day. According to the World Health Organization, COPD afflicts some 50 million people around the world, and kills nearly 3 million every year. In addition, COPD is greatly under-diagnosed, with recent studies indicating that 25% to 50% of clinically significant COPD cases remain undetected. Philips will become an active member of the GOLD initiative by sponsoring and contributing to the education of primary care physicians and patients.

"Philips is proud to partner with GOLD. We are convinced that the collaboration will provide a mutual platform for improved access to treatment for COPD patients," comments Brent Shafer, Executive Vice President Philips Home Healthcare Solutions. "We are committed to providing a complete range of solutions from drug delivery, oxygen therapy and ventilation, to optimize the management of COPD patients."

As part of its focus on delivering innovative and meaningful solutions, Philips recently unveiled the new UltraFill home oxygen filling system in the US, allowing respiratory patients to manage their home oxygen system in a simpler way. The new system combines a stationary oxygen concentrator, 200 bar cylinder filling station, and long-lasting dispensing cylinders to cost-effectively meet the needs of a wide range of oxygen patients, including those who are highly active or require continuous flow oxygen. The UltraFill home oxygen filling system will soon be available in Europe.

In patients suffering from COPD, the airways of the lungs become narrowed, causing a limitation of the flow of air to and from the lungs and shortness of breath. In the initial phase of the disease, patients mostly suffer from breathlessness during physical effort, but as the disease progresses breathlessness also occurs during everyday activities.

"Lifestyle management plays an important role in the treatment of the condition. However, it is vital to provide COPD sufferers with comprehensive treatment options. In addition to the UltraFill oxygen filling systems, Philips provides a range of other devices which can be used to optimize drug delivery in COPD patients, as well as a complete range of oxygen concentrators for COPD treatment," concluded Brent Shafer.

The GOLD initiative (www.goldcopd.com) was launched in 1997 in collaboration with such leading groups as the World Health Organization, with the objective of raising COPD awareness globally. As part of its mission, GOLD focuses on decreasing morbidity and mortality from COPD through the implementation and evaluation of effective programs for diagnosis and management. Philips shares with GOLD a commitment to improve COPD patients' access to treatment throughout the world.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide. With sales of US 32.3 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...